INSIGHT MOLECULAR DIAGNOSTIC (IMDX) Forecast, Price Target & Analyst Ratings

NASDAQ:IMDX • US68235C2061

Current stock price

3.58 USD
-0.41 (-10.28%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INSIGHT MOLECULAR DIAGNOSTIC (IMDX).

Forecast Snapshot

Consensus Price Target

Price Target
$8.50
+ 137.43% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
306K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.50
Upside
+ 137.43%
From current price of $3.58 to mean target of $8.50, Based on 10 analyst forecasts
Low
$4.04
Median
$9.18
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
19.05%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for IMDX. The average price target is 8.5 USD. This implies a price increase of 137.43% is expected in the next year compared to the current price of 3.58.
The average price target has been revised upward by 19.05% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IMDX Current Analyst RatingIMDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

IMDX Historical Analyst RatingsIMDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
78.00%
IMDX was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about IMDX.
In the previous month the buy percentage consensus was at a similar level.
IMDX was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-17Lake StreetMaintains Buy -> Buy
2025-11-11NeedhamMaintains Buy -> Buy
2025-08-18NeedhamReiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
306K
Revenue Q2Q
-85.69%
EPS Q2Q
-2.59%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
-42.08%
Revenue (3 Months)
-42.08%
EPS (1 Month)
-30.75%
EPS (3 Months)
-30.75%

Next Earnings Summary

IMDX is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.27 USD and the consensus revenue estimate is 306.00K USD.
The next earnings revenue estimate has been revised downward by 42.08% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
IMDX revenue by date.IMDX revenue by date.
1.503M
56.56%		1.881M
25.15%		4.055M
115.58%		2.627M
-35.22%		8.339M
217.43%
EBITDA
YoY % growth
IMDX ebitda by date.IMDX ebitda by date.
-14.826M
-300.08%		-17.408M
-17.42%		-34.244M
-96.71%		-26.571M
22.41%		-31.62M
-19.00%
EBIT
YoY % growth
IMDX ebit by date.IMDX ebit by date.
-16.506M
-853.70%		-18.972M
-14.94%		-36.441M
-92.08%		-27.649M
24.13%		-22.95M
16.99%
Operating Margin
IMDX operating margin by date.IMDX operating margin by date.
-1,098.20%-1,008.61%-898.67%-1,052.49%-275.21%
EPS
YoY % growth
IMDX eps by date.IMDX eps by date.
-3.60
72.73%		-4.40
-22.22%		-1.62
63.18%		-0.97
40.41%		-0.88
8.40%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.27
-2.59%		-0.25
16.53%		-0.23
32.43%		-0.22
69.29%		-0.16
40.34%		-0.16
37.00%		-0.15
34.44%		-0.14
35.87%
Revenue
Q2Q % growth		306K
-85.69%		544.68K
5.15%		664.785K
155.69%		1.286M
12.91%		1.836M
500.00%		2.142M
293.26%		2.754M
314.27%		3.468M
169.67%
EBITDA
Q2Q % growth		-7.446M
-18.04%		-8.262M
6.03%		-8.568M
8.18%		-8.466M
-27.54%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-8.222M
-20.93%		-7.533M
23.46%		-7.493M
31.66%		-7.078M
19.89%		-6.426M
21.84%		-5.916M
21.47%		-5.202M
30.58%		-4.59M
35.15%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IMDX Yearly Revenue VS EstimatesIMDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M
IMDX Yearly EPS VS EstimatesIMDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INSIGHT MOLECULAR DIAGNOSTIC / IMDX Forecast FAQ

What is the average price target for INSIGHT MOLECULAR DIAGNOSTIC (IMDX) stock?

10 analysts have analysed IMDX and the average price target is 8.5 USD. This implies a price increase of 137.43% is expected in the next year compared to the current price of 3.58.

What is the next earnings date for IMDX stock?

INSIGHT MOLECULAR DIAGNOSTIC (IMDX) will report earnings on 2026-05-11.

Can you provide the consensus estimates for INSIGHT MOLECULAR DIAGNOSTIC next earnings?

The consensus EPS estimate for the next earnings of INSIGHT MOLECULAR DIAGNOSTIC (IMDX) is -0.27 USD and the consensus revenue estimate is 306.00K USD.